Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00038623
Status:
COMPLETED
Last Update Posted:
2011-11-02
First Post:
2002-06-03
Brief Title:
Study Of Yttrium-ibritumomab Zevalin For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma
Sponsor:
Organization:
MD Anderson Cancer Center